| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 8 | +37.50% | +3.95% | +0.46% | +3.50% | -0.53% | — |
| 14d | 8 | +37.50% | -3.14% | +0.41% | -3.54% | -1.34% | — |
| 30d | 8 | +25.00% | -4.26% | +1.96% | -6.22% | -9.30% | — |
| 60d | 8 | +25.00% | -16.83% | +1.27% | -18.11% | -16.00% | — |
| 90d | 8 | +12.50% | -30.46% | +1.03% | -31.49% | -32.22% | — |
| 180d | 8 | +12.50% | -40.83% | -2.25% | -38.58% | -54.42% | — |
| 1y | 8(1 pending) | +14.29% | +53.73% | -4.85% | +58.58% | -64.19% | — |
| 2y | 8(2 pending) | +0.00% | -90.98% | +8.30% | -99.28% | -98.32% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 287 | — | — | 9,941 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,533 | — | — | 8,489 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 287 | — | — | 27,070 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,165 | — | — | 27,357 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,165 | — | — | 9,654 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 1,533 | — | — | 28,522 | Jul 1, 2026 | Jul 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,443 | — | — | 30,055 | May 14, 2026 | May 18, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 3,443 | — | — | 3,443 | May 14, 2026 | May 18, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 38,323 | — | — | 694,451 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 29,129 | — | — | 665,322 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 29,129 | — | — | 173,913 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 38,323 | — | — | 144,784 | Apr 1, 2026 | Apr 1, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 349,541 | — | — | 349,541 | Feb 25, 2026 | Feb 27, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 349,542 | — | — | 732,774 | Feb 25, 2026 | Feb 27, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 38,323 | — | — | 383,232 | Jan 1, 2026 | Jan 2, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 38,323 | — | — | 106,461 | Jan 1, 2026 | Jan 2, 2026 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 20,000 | $0.51 | $10.2K | 68,138 | Nov 4, 2025 | Nov 5, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | SALE Chief Financial Officer | 38,323 | — | — | 421,555 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 38,323 | — | — | 48,138 | Oct 1, 2025 | Oct 3, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 459,878 | — | — | 459,878 | Aug 13, 2025 | Aug 15, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,379,636 | — | — | 1,379,636 | Aug 13, 2025 | Aug 15, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 1,379,636 | — | — | 1,379,636 | Aug 13, 2025 | Oct 3, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 459,878 | — | — | 459,878 | Aug 13, 2025 | Oct 3, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 60,020 | — | — | 60,020 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 46,074 | — | — | 46,074 | Sep 11, 2024 | Sep 12, 2024 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,098 | $1.27 | $5.2K | 9,815 | Sep 10, 2024 | Sep 11, 2024 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 9,804 | — | — | 9,804 | May 8, 2024 | May 10, 2024 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 4,902 | $2.04 | $10.0K | 5,717 | May 8, 2024 | May 10, 2024 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,933 | — | — | 18,933 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 104,404 | — | — | 104,404 | Feb 15, 2023 | Feb 17, 2023 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 3,000 | $0.67 | $2.0K | 12,230 | Apr 26, 2022 | Apr 27, 2022 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 2,000 | $1.10 | $2.2K | 9,230 | Mar 1, 2022 | Mar 3, 2022 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,000 | $1.86 | $1.9K | 7,230 | Nov 2, 2021 | Nov 4, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 2,000 | $1.67 | $3.3K | 6,230 | Oct 26, 2021 | Oct 27, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 2,244 | $1.91 | $4.3K | 4,230 | Jul 28, 2021 | Jul 29, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASE Chief Financial Officer | 1,986 | $2.05 | $4.1K | 1,986 | Jul 27, 2021 | Jul 29, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,197 | — | — | 100,197 | May 25, 2021 | May 27, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 66,625 | — | — | 66,625 | Feb 16, 2021 | Feb 18, 2021 ↗ | View → |
| PSTV PLUS THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 40,000 | — | — | 40,000 | Feb 6, 2020 | Feb 10, 2020 ↗ | View → |